BIOREM Inc.
BRM.V
TSX
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 104.56% | 21.55% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 104.56% | 21.55% | |||
| Cost of Revenue | 75.36% | 34.37% | |||
| Gross Profit | 203.99% | -8.26% | |||
| SG&A Expenses | 76.39% | -7.45% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 75.24% | 24.84% | |||
| Operating Income | 492.37% | -9.86% | |||
| Income Before Tax | 547.14% | -2.03% | |||
| Income Tax Expenses | 547.49% | -0.22% | |||
| Earnings from Continuing Operations | 547.28% | -2.70% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 547.28% | -2.70% | |||
| EBIT | 492.37% | -9.86% | |||
| EBITDA | 448.60% | -8.73% | |||
| EPS Basic | 543.67% | -3.07% | |||
| Normalized Basic EPS | 540.74% | -1.46% | |||
| EPS Diluted | 555.30% | -6.38% | |||
| Normalized Diluted EPS | 542.98% | -4.20% | |||
| Average Basic Shares Outstanding | 0.65% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.63% | 2.29% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
